ARWR vs ASML · rev $829.4M vs P/E 57, $665.37B cap
Arrowhead Pharmaceuticals Inc (ARWR) versus ASML Holding NV ADR (ASML) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
ASML does not have a complete income-statement cache yet.
ARWR currently screens at market cap $10.59B. ASML currently screens at market cap $665.37B and trailing P/E 57.5.
Not investment advice. Open the ARWR and ASML stock pages for the full models.
Not investment advice.